Request Trial

All in-house stories

Reset all filters
Channels & Sectors
Geography
Company
Refine search
The UPC plugs another gap in its procedural rulebook
MedTech
The UPC plugs another gap in its procedural rulebook
A new UPC Court of Appeal ruling closes an important procedural gap, with significant implications for how in-house teams structure validity defences, manage litigation costs and prepare for appeals, says Florian Laus of Simmons & Simmons.   7 August 2026
Exclusive: Winston Taylor’s UK head of IP on pitching $1.75bn firm’s ‘humble, but lethal’ practice
In-house counsel
Exclusive: Winston Taylor’s UK head of IP on pitching $1.75bn firm’s ‘humble, but lethal’ practice
A transatlantic firm with intellectual property at its heart—what’s not to like? The firm’s 30-year veteran tells WIPR why leading a recruitment drive is a “big responsibility” as the combined firm looks to out-scale the opposition.   4 August 2026
Where Big Pharma is betting big in the M&A boom
Regulation & Industry
Where Big Pharma is betting big in the M&A boom
Dealmaking is at a record pace, but not every asset is in play. So what are the therapy areas commanding the fiercest bidding wars and what’s to come?   29 July 2026
Regulation & Industry
Buying the brains: Why is Big Pharma shopping for innovation?
With billions in revenue set to disappear as patents expire, pharmaceutical giants are racing to acquire their way out of trouble. But are there other drivers behind the surge—and how long can the momentum last?   27 July 2026
In-house counsel
‘Engagement and collaboration’: New IP Federation president builds on strong foundations
As Philips' Kevin Scott becomes the IP Federation’s new president, Sarah Speight discovers the key issues facing the membership body for in-house counsel.   24 July 2026
Regulation & Industry
Why is 2026 already a record year for M&A activity?
Blockbuster acquisitions are back, impacting the pharma industry at record pace. As billions flow into breakthrough science, LSIPR’s series explores what’s driving the surge, how today’s deals are done, and where IP comes into the picture.   17 July 2026
Careers
IP Federation elects Philips licensing leader as new president
Kevin Scott will lead the organisation representing in-house counsel in the UK, for companies such as AstraZeneca, Eli Lilly, MSD and Regeneron.   14 July 2026
In-house counsel
Interview: How BlueRock Therapeutics is layering IP in stem cell therapies
The company’s VP of IP explains how he is protecting the process, staying ahead of outside counsel, and why a biosimilar path is only a matter of time.   13 July 2026
Biotech
Explaining genetically engineered rodents to a jury—and ultimately beating Amgen
Harbour’s trial counsel shares the strategy behind the company’s $20m win, revealing how a highly technical patent dispute became a case about credibility as much as science.   10 July 2026
Careers
HGF expands European offering with pair of in-house hires
The firm has appointed two new partners in Basel and Bristol, adding decades of expertise from the pharmaceutical and biotech sectors to its growing life sciences practice.   2 July 2026